New biomarker could help predict Parkinson’s disease progression

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson’s disease progression.

Cantourage Group SE (von NuWays AG) – Biotech Investments

Original-Research: Cantourage Group SE – from NuWays AG 06.12.2024 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group

December 7, 2024

Ulotaront hydrochloride by Sumitomo Pharma America for Generalized Anxiety Disorder (GAD): Likelihood of Approval

Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III for Generalized Anxiety Disorder (GAD).

March 19, 2024

Changing the Surgical Paradigm in Oligometastatic NSCLC

Patients with single-site synchronous oligometastatic non-small cell lung cancer (NSCLC) had better overall survival (OS) when they received surgery for their primary tumor, a retrospective

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.